Literature DB >> 19240862

Ultrastructural signs of cyclophosphamide-induced damage to cardiomyocytes.

E L Lushnikova1, L M Nepomnyashchikh, E A Sviridov, M G Klinnikova.   

Abstract

Ultrastructural changes in rat cardiomyocytes were studied after single administration of cyclophosphamide in the therapeutic dose. The major signs of cyclophosphamide-induced damage to cardiomyocytes included moderate lysis of myofibrils, dilation of vesicles in the granular and agranular sarcoplasmic reticulum, and destruction of mitochondria with the formation of myelin-like residual bodies. Ultrastructural changes in cardiomyocyte nuclei primarily manifested in variations of the shape, deep invaginations of the nuclear membrane, and translocation into the subsarcolemmal region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19240862     DOI: 10.1007/s10517-008-0287-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.

Authors:  Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W McAleer; Christopher J Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A Carmona-Moran; Trevor Sasserath; Daniel H Elbrecht; Lee Kumanchik; L Richard Bridges; Candace Martin; Mark T Schnepper; Gail Ekman; Max Jackson; Ying I Wang; Reine Note; Jessica Langer; Silvia Teissier; James J Hickman
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

2.  Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.

Authors:  Laura Grois; Julian Hupf; Jörg Reinders; Josef Schröder; Alexander Dietl; Peter M Schmid; Carsten Jungbauer; Markus Resch; Lars S Maier; Andreas Luchner; Christoph Birner
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.